106 related articles for article (PubMed ID: 17362136)
1. Adenovirus-mediated gene transfer of human vascular endothelial growth factor-d induces transient angiogenic effects in mouse hind limb muscle.
Kholová I; Koota S; Kaskenpää N; Leppänen P; Närväinen J; Kavec M; Rissanen TT; Hazes T; Korpisalo P; Gröhn O; Ylä-Herttuala S
Hum Gene Ther; 2007 Mar; 18(3):232-44. PubMed ID: 17362136
[TBL] [Abstract][Full Text] [Related]
2. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses.
Rissanen TT; Markkanen JE; Gruchala M; Heikura T; Puranen A; Kettunen MI; Kholová I; Kauppinen RA; Achen MG; Stacker SA; Alitalo K; Ylä-Herttuala S
Circ Res; 2003 May; 92(10):1098-106. PubMed ID: 12714562
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus encoding vascular endothelial growth factor-D induces tissue-specific vascular patterns in vivo.
Byzova TV; Goldman CK; Jankau J; Chen J; Cabrera G; Achen MG; Stacker SA; Carnevale KA; Siemionow M; Deitcher SR; DiCorleto PE
Blood; 2002 Jun; 99(12):4434-42. PubMed ID: 12036873
[TBL] [Abstract][Full Text] [Related]
4. Myocardial angiogenesis after plasmid or adenoviral VEGF-A(165) gene transfer in rat myocardial infarction model.
Hao X; Månsson-Broberg A; Grinnemo KH; Siddiqui AJ; Dellgren G; Brodin LA; Sylvén C
Cardiovasc Res; 2007 Feb; 73(3):481-7. PubMed ID: 17134685
[TBL] [Abstract][Full Text] [Related]
5. Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis.
Rissanen TT; Korpisalo P; Markkanen JE; Liimatainen T; Ordén MR; Kholová I; de Goede A; Heikura T; Gröhn OH; Ylä-Herttuala S
Circulation; 2005 Dec; 112(25):3937-46. PubMed ID: 16344386
[TBL] [Abstract][Full Text] [Related]
6. Capillary enlargement, not sprouting angiogenesis, determines beneficial therapeutic effects and side effects of angiogenic gene therapy.
Korpisalo P; Hytönen JP; Laitinen JT; Laidinen S; Parviainen H; Karvinen H; Siponen J; Marjomäki V; Vajanto I; Rissanen TT; Ylä-Herttuala S
Eur Heart J; 2011 Jul; 32(13):1664-72. PubMed ID: 21138938
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor-A and platelet-derived growth factor-B combination gene therapy prolongs angiogenic effects via recruitment of interstitial mononuclear cells and paracrine effects rather than improved pericyte coverage of angiogenic vessels.
Korpisalo P; Karvinen H; Rissanen TT; Kilpijoki J; Marjomäki V; Baluk P; McDonald DM; Cao Y; Eriksson U; Alitalo K; Ylä-Herttuala S
Circ Res; 2008 Nov; 103(10):1092-9. PubMed ID: 18832750
[TBL] [Abstract][Full Text] [Related]
8. Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart.
Rutanen J; Rissanen TT; Markkanen JE; Gruchala M; Silvennoinen P; Kivelä A; Hedman A; Hedman M; Heikura T; Ordén MR; Stacker SA; Achen MG; Hartikainen J; Ylä-Herttuala S
Circulation; 2004 Mar; 109(8):1029-35. PubMed ID: 14967735
[TBL] [Abstract][Full Text] [Related]
9. Baculovirus-mediated vascular endothelial growth factor-D(ΔNΔC) gene transfer induces angiogenesis in rabbit skeletal muscle.
Heikura T; Nieminen T; Roschier MM; Karvinen H; Kaikkonen MU; Mähönen AJ; Lesch HP; Rissanen TT; Laitinen OH; Airenne KJ; Ylä-Herttuala S
J Gene Med; 2012 Jan; 14(1):35-43. PubMed ID: 22162149
[TBL] [Abstract][Full Text] [Related]
10. Vascular permeability effect of adenovirus-mediated vascular endothelial growth factor gene transfer to the rabbit and rat skeletal muscle.
Poliakova L; Kovesdi I; Wang X; Capogrossi MC; Talan M
J Thorac Cardiovasc Surg; 1999 Aug; 118(2):339-47. PubMed ID: 10425008
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor-C derived from CD11b+ cells induces therapeutic improvements in a murine model of hind limb ischemia.
Kuwahara G; Nishinakamura H; Kojima D; Tashiro T; Kodama S
J Vasc Surg; 2013 Apr; 57(4):1090-9. PubMed ID: 23219511
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis is confined to the transient period of VEGF expression that follows adenoviral gene delivery to ischemic muscle.
Gounis MJ; Spiga MG; Graham RM; Wilson A; Haliko S; Lieber BB; Wakhloo AK; Webster KA
Gene Ther; 2005 May; 12(9):762-71. PubMed ID: 15772688
[TBL] [Abstract][Full Text] [Related]
13. Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes.
Saaristo A; Veikkola T; Enholm B; Hytönen M; Arola J; Pajusola K; Turunen P; Jeltsch M; Karkkainen MJ; Kerjaschki D; Bueler H; Ylä-Herttuala S; Alitalo K
FASEB J; 2002 Jul; 16(9):1041-9. PubMed ID: 12087065
[TBL] [Abstract][Full Text] [Related]
14. High-resolution ultrasound perfusion imaging of therapeutic angiogenesis.
Rissanen TT; Korpisalo P; Karvinen H; Liimatainen T; Laidinen S; Gröhn OH; Ylä-Herttuala S
JACC Cardiovasc Imaging; 2008 Jan; 1(1):83-91. PubMed ID: 19356410
[TBL] [Abstract][Full Text] [Related]
15. VEGF and angiopoietin-1 stimulate different angiogenic phenotypes that combine to enhance functional neovascularization in adult tissue.
Benest AV; Salmon AH; Wang W; Glover CP; Uney J; Harper SJ; Bates DO
Microcirculation; 2006 Sep; 13(6):423-37. PubMed ID: 16864410
[TBL] [Abstract][Full Text] [Related]
16. Angiogenic responses of vascular endothelial growth factors in periadventitial tissue.
Bhardwaj S; Roy H; Gruchala M; Viita H; Kholova I; Kokina I; Achen MG; Stacker SA; Hedman M; Alitalo K; Ylä-Herttuala S
Hum Gene Ther; 2003 Oct; 14(15):1451-62. PubMed ID: 14577925
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 4 induces vascular permeability, angiogenesis and arteriogenesis in a rabbit hindlimb ischemia model.
Rissanen TT; Markkanen JE; Arve K; Rutanen J; Kettunen MI; Vajanto I; Jauhiainen S; Cashion L; Gruchala M; Närvänen O; Taipale P; Kauppinen RA; Rubanyi GM; Ylä-Herttuala S
FASEB J; 2003 Jan; 17(1):100-2. PubMed ID: 12475908
[TBL] [Abstract][Full Text] [Related]
18. An engineered vascular endothelial growth factor-activating transcription factor induces therapeutic angiogenesis in ApoE knockout mice with hindlimb ischemia.
Xie D; Li Y; Reed EA; Odronic SI; Kontos CD; Annex BH
J Vasc Surg; 2006 Jul; 44(1):166-75. PubMed ID: 16753278
[TBL] [Abstract][Full Text] [Related]
19. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.
Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM
J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531
[TBL] [Abstract][Full Text] [Related]
20. Gene transfers of vascular endothelial growth factor-A, vascular endothelial growth factor-B, vascular endothelial growth factor-C, and vascular endothelial growth factor-D have no effects on atherosclerosis in hypercholesterolemic low-density lipoprotein-receptor/apolipoprotein B48-deficient mice.
Leppänen P; Koota S; Kholová I; Koponen J; Fieber C; Eriksson U; Alitalo K; Ylä-Herttuala S
Circulation; 2005 Aug; 112(9):1347-52. PubMed ID: 16129816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
